Non-Life Science Products

(Software; Hardware; Consumer; Digital Healthcare)

Seed

• Team: At least one founder full-time or going full-time with the current raise

• Product: At minimum - a functional MVP

• Market Opportunity: well defined-market and/or strong demand pipeline

• Revenue: Minimum of $200k ARR with a clear path to $500k+ in 12 months

• Financials: Fundraise will provide 12+ months of runway

• Customers: Demonstration of paying interest and diversity in number of existing customers

• Instrument: Priced Round preferred - open to convertible notes

Series A

• Round Dynamics: Minimum of one institutional investor participating

• Team: Core team is full-time

• Product: Scalable product built and operational

• Traction: Paying customers and strong awareness of market segments; Diversified customer list; Demonstration of customer renewal

• Revenue: Minimum of $500k ARR in trailing 12 months with a clear path to $1M ARR

• Financials: Fundraise will provide 12+ months of runway

• Pipeline: Clear five year pro forma for growth and established metrics around pipeline

• Instrument: Priced Round

Life Science Companies

(Medical Device; Therapeutics; Diagnostics)

• Round Dynamics: Minimum of one institutional investor participating

• Team: At least one founder full-time or going full-time with the current raise

• Near-term FDA approval timeline with initial FDA meeting providing positive written feedback

• Defined segment with understanding of payment model

• Referenceable customers and notable partnerships

• Studies: Early studies and research demonstrating clinical potential (FIH success in US or non-US)

• Instrument: Priced Round